BrightSpring Health
BTSG
BrightSpring Health (BTSG) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.45
- EPS estimate
- $0.40
- EPS surprise
- +13.55%
- Revenue surprise
- +5.80%
- Revenue
- $3.9B
- Revenue estimate
- $3.7B
- Reported
- Jul 31, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 31, 2026 | $0.40 | $0.45 | +13.55% | $3.9B | SEC |
| Q1 2026 | May 1, 2026 | $0.31 | $0.39 | +26.25% | $3.6B | SEC |
| Q4 2025 | Feb 27, 2026 | $0.34 | $0.33 | −3.85% | $3.6B | SEC |
| Q3 2025 | Oct 20, 2025 | $0.25 | $0.30 | +21.07% | $3.3B | SEC |
| Q2 2025 | Aug 1, 2025 | $0.19 | $0.22 | +17.58% | $3.1B | SEC |
| Q1 2025 | May 2, 2025 | $0.09 | $0.19 | +108.79% | $2.9B | SEC |
| Q4 2024 | Mar 6, 2025 | $0.21 | $0.22 | +3.82% | $3.1B | SEC |
| Q3 2024 | Nov 1, 2024 | $0.15 | $0.11 | −28.53% | $2.9B | SEC |
| Q2 2024 | Aug 2, 2024 | $0.13 | $0.10 | −25.87% | $2.7B | SEC |
| Q1 2024 | May 2, 2024 | $0.04 | $0.12 | +220.00% | $2.6B | SEC |
| Q4 2023 | Feb 29, 2024 | $0.10 | −$0.06 | −157.42% | $2.4B | SEC |
Quarterly revenue
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.